pI: 5.1195 |
Length (AA): 396 |
MW (Da): 43562 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 395 | 3avx (A) | 279 | 677 | 72.00 | 0 | 1 | 1.73557 | -0.27 |
8 | 395 | 5w7q (A) | 8 | 393 | 78.00 | 0 | 1 | 1.892 | -0.93 |
9 | 396 | 5w75 (A) | 9 | 394 | 69.00 | 0 | 1 | 1.854 | -1.05 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126954)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G20360 | RAB GTPase homolog E1b |
Arabidopsis thaliana | AT4G02930 | putative elongation factor Tu |
Babesia bovis | BBOV_III001500 | translation elongation factor Tu |
Babesia bovis | BBOV_V000220 | EFTU_STAAS Elongation factor Tu, putative |
Brugia malayi | Bm1_54320 | elongation factor Tu homologue precursor |
Candida albicans | CaO19.13468 | translation elongation factor Tu |
Candida albicans | CaO19.6047 | translation elongation factor Tu |
Caenorhabditis elegans | CELE_Y71H2AM.23 | Protein TUFM-1 |
Chlamydia trachomatis | CT_322 | elongation factor Tu |
Dictyostelium discoideum | DDB_G0289593 | elongation factor Tu domain-containing protein |
Drosophila melanogaster | Dmel_CG6050 | Elongation factor Tu mitochondrial |
Escherichia coli | b3980 | translation elongation factor EF-Tu 2 |
Escherichia coli | b3339 | translation elongation factor EF-Tu 1 |
Echinococcus granulosus | EgrG_000102600 | elongation factor tu ef tu |
Echinococcus multilocularis | EmuJ_000102600 | elongation factor tu (ef tu) |
Homo sapiens | ENSG00000178952 | Tu translation elongation factor, mitochondrial |
Leishmania braziliensis | LbrM.18.0830 | elongation factor Tu, putative |
Leishmania donovani | LdBPK_180740.1 | Elongation factor Tu, mitochondrial, putative |
Leishmania infantum | LinJ.18.0740 | elongation factor Tu, putative |
Leishmania major | LmjF.18.0740 | elongation factor Tu, putative |
Leishmania mexicana | LmxM.18.0740 | elongation factor Tu, putative |
Loa Loa (eye worm) | LOAG_10636 | elongation factor Tu1 |
Loa Loa (eye worm) | LOAG_11346 | elongation factor Tu |
Mycobacterium leprae | ML1877c | PROBABLE IRON-REGULATED ELONGATION FACTOR TU TUF (EF-TU) |
Mus musculus | ENSMUSG00000073838 | Tu translation elongation factor, mitochondrial |
Mycobacterium tuberculosis | Rv0685 | Probable iron-regulated elongation factor TU Tuf (EF-TU) |
Mycobacterium ulcerans | MUL_0766 | elongation factor Tu |
Mycobacterium ulcerans | MUL_2857 | iron-regulated elongation factor Tu Tuf-like |
Neospora caninum | NCLIV_025450 | elongation factor Tu, putative |
Oryza sativa | 9270837 | Os02g0595700 |
Oryza sativa | 4334800 | Os03g0851100 |
Plasmodium berghei | PBANKA_1345600 | elongation factor Tu, putative |
Plasmodium berghei | PBANKA_API00280 | elongation factor Tu, putative |
Plasmodium falciparum | PF3D7_1330600 | elongation factor Tu, putative |
Plasmodium falciparum | PF3D7_API02900 | elongation factor Tu |
Plasmodium knowlesi | PKNH_1269800 | elongation factor Tu, putative |
Plasmodium knowlesi | PKNH_API03800 | elongation factor Tu, putative |
Plasmodium vivax | PVX_082470 | elongation factor Tu, mitochondrial precursor, putative |
Plasmodium yoelii | PY05361 | translation elongation factor Tu |
Plasmodium yoelii | PY06134 | translation elongation factor Tu |
Saccharomyces cerevisiae | YOR187W | translation elongation factor Tu |
Schistosoma japonicum | Sjp_0215290 | ko:K02358 elongation factor EF-Tu, putative |
Schistosoma mansoni | Smp_073500.1 | elongation factor tu (ef-tu) |
Schistosoma mansoni | Smp_073500.2 | elongation factor tu (ef-tu) |
Schmidtea mediterranea | mk4.012288.00 | Elongation factor Tu, mitochondrial |
Schmidtea mediterranea | mk4.002140.01 | |
Schmidtea mediterranea | mk4.008229.00 | Elongation factor Tu, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.10.16140 | elongation factor Tu, putative |
Trypanosoma brucei | Tb927.10.13360 | Elongation factor Tu, mitochondrial |
Trypanosoma congolense | TcIL3000_10_11450 | Elongation factor Tu, mitochondrial, putative |
Trypanosoma cruzi | TcCLB.506357.40 | Elongation factor Tu, mitochondrial, putative |
Trypanosoma cruzi | TcCLB.511277.70 | Elongation factor Tu, mitochondrial, putative |
Toxoplasma gondii | TGME49_302060 | elongation factor tu, apicoplast, putative |
Toxoplasma gondii | TGME49_262380 | elongation factor Tu, putative |
Toxoplasma gondii | TGME49_302050 | elongation factor tu, apicoplast, putative |
Treponema pallidum | TP0187 | elongation factor Tu |
Theileria parva | TP05_0019 | elongation factor TU, putative |
Theileria parva | TP03_0698 | elongation factor Tu, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0343 | elongation factor Tu |
Wolbachia endosymbiont of Brugia malayi | Wbm0653 | elongation factor Tu |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.13360 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.13360 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.13360 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.13360 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3339 | Escherichia coli | non-essential | goodall |
b3980 | Escherichia coli | non-essential | goodall |
CELE_Y71H2AM.23 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y71H2AM.23 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y71H2AM.23 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_1345600 | Plasmodium berghei | Essential | plasmo |
TGME49_262380 | Toxoplasma gondii | Probably essential | sidik |
TGME49_302050 | Toxoplasma gondii | Probably essential | sidik |
TGME49_302060 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.